<DOC>
	<DOCNO>NCT01717183</DOCNO>
	<brief_summary>The main purpose trial demonstrate new dress effective current dress local treatment chronic foot ulcer diabetic patient .</brief_summary>
	<brief_title>Assessment Efficacy Safety New Wound Dressing Local Treatment Diabetic Foot Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>Male female 18 year old provide his/her write informed consent Patient cover French national insurance system Patient Type 1 Type 2 diabetes mellitus glycated hemoglobi ( HbA1c ) level ≤ 10 % ( assay previous 3 month . If available , assay must perform runin period ) Inpatient outpatient monitor investigate team throughout duration study Patient agree wear prescribed offload system every day , associate test dress DFU adequate arterial blood supply target limb DFU grade IC IIC define University Texas Diabetic Wound Classification Neuropathy confirm loss protective sensation monofilament test ( SemmesWeinstein 5.07 monofilament ) DFU locate toe lateral , dorsal plantar side foot Target DFU surface area 1 cm² 30 cm² , follow debridement DFU duration 1 24 month No local clinical infection ( define IDSA/IWGDF criterion ) wound ( target DFU ) low limbs DFU adequately debrided Pregnant breastfeed woman woman childbearing potential use effective mean contraception Patient take part another clinical trial previous month take part another clinical trial 20 week follow inclusion Patient know intolerance allergy report adverse reaction one components trial dressing Patient undergone surgery surgical revascularization ( vascular reconstruction angioplasty ) previous 2 month Patient present acute ischemic event ( Acute Myocardial Infarction ( AMI ) stroke ) 3 month inclusion Patient Severe kidney failure , define requirement dialysis Patient systemic infection control suitable antibiotic treatment Patient know osteomyelitis Patient leg ulcer ( ) , regardless limb Patient wound target DFU locate heel interdigital part foot Patient active neoplastic condition , treat radiotherapy , chemotherapy , hormone therapy immunosuppressant agent Patient treat chronic disease require high dos systemic corticosteroid ( ≥ 40 mg.d1 prednisolone equivalent ) Patient severe illness might lead premature withdrawal trial DFU surgery surgical revascularization plan time study Deep DFU define stage III IV ( University Texas Diabetic Wound Classification ) DFU clinically infect defined IDSA/IWGDF criterion DFU 20 % surface area cover black necrotic tissue follow debridement DFU locate amputation stump DFU neoplastic component</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2014</verification_date>
	<keyword>Patient</keyword>
</DOC>